Pacira reported $363.12M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Astellas Pharma JPY 565.95B 265.47B Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Cara Therapeutics USD 0 0 Mar/2025
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 54.99B 7.05B Mar/2026
Ligand Pharmaceuticals USD 451.98M 486K Mar/2026
Nektar Therapeutics USD 0 0 Jun/2022
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Omeros USD 442.16M 199K Sep/2023
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.63B 7.7M Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Supernus Pharmaceuticals USD 40.9M 74K Mar/2026
Teva Pharmaceutical Industries USD 16.91B 187M Mar/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026
Zoetis USD 9.24B 0 Mar/2026